Vanda Pharmaceuticals Inc (VNDA.OQ)

VNDA.OQ on NASDAQ Stock Exchange Global Market

7.94USD
2:45pm EST
Change (% chg)

-- (+0.00%)
Prev Close
$7.94
Open
$7.99
Day's High
$8.03
Day's Low
$7.51
Volume
101,391
Avg. Vol
260,247
52-wk High
$14.49
52-wk Low
$6.91

VNDA.OQ

Chart for VNDA.OQ

About

Vanda Pharmaceuticals Inc. is a biopharmaceutical company. The Company is focused on the development and commercialization of pharmaceutical products for the treatment of central nervous system (CNS) disorders. The Company's product portfolio includes HETLIOZ (tasimelteon), Fanapt (iloperidone), Tradipitant (VLY-686), Trichostat... (more)

Overall

Beta: 1.72
Market Cap(Mil.): $339.95
Shares Outstanding(Mil.): 42.82
Dividend: --
Yield (%): --

Financials

  VNDA.OQ Industry Sector
P/E (TTM): -- 57.04 37.63
EPS (TTM): -0.94 -- --
ROI: -24.48 6.34 14.09
ROE: -27.13 8.38 14.83
Search Stocks

Competitors

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider : Thomson Reuters Stock Report
$25.00
Provider : Stock Traders Daily
$20.00
Provider : New Constructs, LLC
$25.00
Provider : ValuEngine, Inc.
$25.00
Provider : S&P Capital IQ Quantitative Report
$115.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks